Ann: Creso Pharma completes US OTC dual listing, page-51

From Next Investors web site . ASX:CPH is a medium term investment we hold and write about that is not currently in the portfolio above. We took a position at 3c in October 2020 as a short term hold which upgraded to a medium hold after the company delivered. On March 26 2021 we increased our position at 19c. We are considering adding CPH to our long term portfolio if it can deliver a few more key milestones.

Is anyone here looking for a longterm hold . I would think their backing for a medium term hold is recommendation enough. Talk about downramping.